Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Aherne

Showing results (41-50 of 139) with videos related to

Pageof 14
Sort By:
Clinical Science and Molecular Medicine|May 1, 1975
The characteristics of ferritin from human tissues, serum and blood cellsM Worwood, W Aherne, S Dawkins, et al.
British Journal of Cancer|November 1, 1977
Development and application of a radioimmunoassay for methotrexateG W Aherne, E M Piall, V Marks
Journal of Clinical Pathology|June 1, 1977
Macrophage infiltration of breast tumours: a prospective studyI Lauder, W Aherne, J Stewart, et al.
Clinical Biochemistry|June 1, 1985
ChronopharmacologyV Marks, J English, W Aherne, et al.
Advances in Experimental Medicine and Biology|January 1, 1994
The measurement of deoxynucleotide (dNTP) pools by radioimmunoassay (RIA)W Aherne, A Hardcastle, L Kelland, et al.
The Journal of Pharmacy and Pharmacology|October 1, 1990
Cytotoxic drugs and the aquatic environment: estimation of bleomycin in river and water samplesG W Aherne, A Hardcastle, A H Nield
The Analyst|October 1, 1989
Enhanced chemiluminescent enzyme immunoassay for cannabinoids in urineJ D Sharma, G W Aherne, V Marks
Cancer Research|May 1, 1991
Mechanism of cell death following thymidylate synthase inhibition: 2'-deoxyuridine-5'-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamoleN J Curtin, A L Harris, G W Aherne
British Journal of Clinical Pharmacology|December 1, 1979
Serum morphine concentration after oral administration of diamorphine hydrochloride and morphine sulphateG W Aherne, E M Piall, R G Twycross
Cancer Treatment Reports|June 1, 1982
Development and application of a radioimmunoassay for pepleomycinG W Aherne, N Saesow, S James, et al.
Pageof 14

Showing results (41-50 of 139) with videos related to

Sort By:
Pageof 14
Clinical Science and Molecular Medicine|May 1, 1975
The characteristics of ferritin from human tissues, serum and blood cellsM Worwood, W Aherne, S Dawkins, et al.
British Journal of Cancer|November 1, 1977
Development and application of a radioimmunoassay for methotrexateG W Aherne, E M Piall, V Marks
Journal of Clinical Pathology|June 1, 1977
Macrophage infiltration of breast tumours: a prospective studyI Lauder, W Aherne, J Stewart, et al.
Clinical Biochemistry|June 1, 1985
ChronopharmacologyV Marks, J English, W Aherne, et al.
Advances in Experimental Medicine and Biology|January 1, 1994
The measurement of deoxynucleotide (dNTP) pools by radioimmunoassay (RIA)W Aherne, A Hardcastle, L Kelland, et al.
The Journal of Pharmacy and Pharmacology|October 1, 1990
Cytotoxic drugs and the aquatic environment: estimation of bleomycin in river and water samplesG W Aherne, A Hardcastle, A H Nield
The Analyst|October 1, 1989
Enhanced chemiluminescent enzyme immunoassay for cannabinoids in urineJ D Sharma, G W Aherne, V Marks
Cancer Research|May 1, 1991
Mechanism of cell death following thymidylate synthase inhibition: 2'-deoxyuridine-5'-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamoleN J Curtin, A L Harris, G W Aherne
British Journal of Clinical Pharmacology|December 1, 1979
Serum morphine concentration after oral administration of diamorphine hydrochloride and morphine sulphateG W Aherne, E M Piall, R G Twycross
Cancer Treatment Reports|June 1, 1982
Development and application of a radioimmunoassay for pepleomycinG W Aherne, N Saesow, S James, et al.
Pageof 14